Pityriasis versicolor epidemiology, disease predictors, and health care utilization: Analysis of 32,679 cases in a large commercial insurance database

Jeremy A W Gold; Kaitlin Benedict; Shari R Lipner

doi:10.1016/j.jaad.2024.09.052

Pityriasis versicolor epidemiology, disease predictors, and health care utilization: Analysis of 32,679 cases in a large commercial insurance database

J Am Acad Dermatol. 2024 Oct 9:S0190-9622(24)02958-X. doi: 10.1016/j.jaad.2024.09.052. Online ahead of print.

Authors

Jeremy A W Gold¹, Kaitlin Benedict², Shari R Lipner³

Affiliations

¹ Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia. Electronic address: [email protected].
² Mycotic Diseases Branch, Centers for Disease Control and Prevention, Atlanta, Georgia.
³ Department of Dermatology, Weill Cornell Medicine, New York, New York.

PMID: 39389424
DOI: 10.1016/j.jaad.2024.09.052

No abstract available

Keywords: United States; antifungal stewardship; culture; direct microscopy; epidemiology; fluconazole; griseofulvin; itraconazole; ketoconazole; pityriasis versicolor; polymerase chain reaction; selenium sulfide; terbinafine; tinea versicolor; treatment.